IN2013MU02001A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU02001A IN2013MU02001A IN2001MU2013A IN2013MU02001A IN 2013MU02001 A IN2013MU02001 A IN 2013MU02001A IN 2001MU2013 A IN2001MU2013 A IN 2001MU2013A IN 2013MU02001 A IN2013MU02001 A IN 2013MU02001A
- Authority
- IN
- India
- Prior art keywords
- formula
- solid obtained
- compound
- vilazodone
- solution
- Prior art date
Links
- 239000007787 solid Substances 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000002904 solvent Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- 229960003740 vilazodone Drugs 0.000 abstract 2
- SGEGOXDYSFKCPT-UHFFFAOYSA-N vilazodone Chemical compound C1=C(C#N)C=C2C(CCCCN3CCN(CC3)C=3C=C4C=C(OC4=CC=3)C(=O)N)=CNC2=C1 SGEGOXDYSFKCPT-UHFFFAOYSA-N 0.000 abstract 2
- VLDBEGOSVWUFMW-UHFFFAOYSA-N O=C=C1Cc2cc(ccc2O1)N1CCN(CCCCc2c[nH]c3ccc(cc23)C#N)CC1 Chemical compound O=C=C1Cc2cc(ccc2O1)N1CCN(CCCCc2c[nH]c3ccc(cc23)C#N)CC1 VLDBEGOSVWUFMW-UHFFFAOYSA-N 0.000 abstract 1
- 230000001476 alcoholic effect Effects 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
- 150000007529 inorganic bases Chemical class 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000002002 slurry Substances 0.000 abstract 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 abstract 1
- 235000010262 sodium metabisulphite Nutrition 0.000 abstract 1
- 239000004296 sodium metabisulphite Substances 0.000 abstract 1
- 229960003381 vilazodone hydrochloride Drugs 0.000 abstract 1
- RPZBRGFNBNQSOP-UHFFFAOYSA-N vilazodone hydrochloride Chemical compound Cl.C1=C(C#N)C=C2C(CCCCN3CCN(CC3)C=3C=C4C=C(OC4=CC=3)C(=O)N)=CNC2=C1 RPZBRGFNBNQSOP-UHFFFAOYSA-N 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a process for preparation of substantially pure Vilazodone Hydrochloride and also relates to an isolated impurity of Vilazodone. The said process for producing Vilazodone, 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbonyl benzofuran-5-yl) piperazine represented by formula (1) or a pharmaceutically acceptable salt thereof comprises condensing the compound of formula (2) With a compound of formula (3) in an alcoholic solvent to obtain a white to yellow solid; isolating the solid obtained therefrom; slurry washing the solid obtained with water miscible solvent; dissolving the solid obtained therefrom in an amide solvent to obtain a solution; adding an aqueous solution of sodium metabisulphite and an inorganic base to the solution obtained to obtain the compound of formula (1) and optionally converting the solid obtained in step (v) to its pharmaceutically acceptable salt.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2014/062132 WO2014199313A1 (en) | 2013-06-12 | 2014-06-11 | Substantially pure vilazodone hydrochloride and a process thereof |
| IN2001MU2013 IN2013MU02001A (en) | 2013-06-12 | 2014-06-11 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2001MU2013 IN2013MU02001A (en) | 2013-06-12 | 2014-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU02001A true IN2013MU02001A (en) | 2015-05-29 |
Family
ID=51355568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2001MU2013 IN2013MU02001A (en) | 2013-06-12 | 2014-06-11 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2013MU02001A (en) |
| WO (1) | WO2014199313A1 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4333254A1 (en) | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidines and piperazines |
| DE19514567A1 (en) | 1995-04-20 | 1996-10-24 | Merck Patent Gmbh | Benzofurans |
| UA76758C2 (en) | 2001-06-19 | 2006-09-15 | Мерк Патент Гмбх | Polymorph forms of hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine |
| DE102005019670A1 (en) | 2005-04-26 | 2006-11-02 | Merck Patent Gmbh | Preparation of 5-(4-(4-(5-cyano-3-indolyl)-butyl)-1-piperazinyl)-benzofuran-2-carboxamide, comprises reacting a heterocyclic compound with a carbonitrile compound; and/or converting the obtained benzofuran compound to its salt |
| WO2014061000A1 (en) * | 2012-10-19 | 2014-04-24 | Ranbaxy Laboratories Limited | Process for the preparation of vilazodone or pharmaceutically acceptable salt thereof |
-
2014
- 2014-06-11 WO PCT/IB2014/062132 patent/WO2014199313A1/en active Application Filing
- 2014-06-11 IN IN2001MU2013 patent/IN2013MU02001A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014199313A1 (en) | 2014-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201201033A1 (en) | CYCLIC AMINE AND ACARICIDE | |
| CY1118332T1 (en) | METHODS OF PRODUCTION OF CYCLOCYL CARBOXAMIDE-PYRIDINO ACID | |
| EA201591239A1 (en) | SUBSTITUTED PHTHALAZIN-1 (2H) -ONEAL DERIVATIVES AS SELECTIVE POLYMERASE INHIBITORS (ADP-RIBOSE) POLYMERASE-1 | |
| RS54686B1 (en) | Quinoline derivative-containing pharmaceutical composition | |
| EA201501122A1 (en) | NEW AGONISTS OF SOMATOSTATIN RECEPTORS OF SUB-TYPE 4 (SSTR4) | |
| PH12015502443A1 (en) | 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
| DK2453739T3 (en) | PROCEDURE FOR PREPARING A WATER SUSPENSION OF AN ORGANIC PESTICID COMPOUND | |
| EA201101026A1 (en) | BETA SECRETASE INHIBITORS | |
| CY1119220T1 (en) | Monocyclic Pyridine Derivative | |
| EA201500930A1 (en) | NEW INHIBITORS | |
| RS54413B1 (en) | [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4trifluoromethoxy-1h-indol-3-yl]methanone as an inhibitor of mast cell tryptase | |
| EA201291280A1 (en) | NEW POLYMORPHIC FORM OF THE FOUNDATION OF IMATINIBE AND OBTAINING ITS SALTS | |
| MX388841B (en) | Processes for preparing ag-10, its intermediates, and salts thereof | |
| MX374426B (en) | SYNTHESIS OF TRIACETONADIAMINE COMPOUNDS BY REDUCTIVE AMINATION PROCEDURE OF TRIACETONADIAMINE AND DERIVATIVES THEREOF. | |
| EA201100696A1 (en) | 1- (ARILSULPHONIL) -4- (PIPERAZIN-1-IL) -1H-BENZIMIDAZOLES AS 5-HYDROXITRIPTAMINE-6 LIGANDS | |
| MX374299B (en) | SYNTHESIS OF TRIACETONADIAMINE COMPOUNDS BY REDUCTIVE AMINATION FROM TRIACETONADIAMINE AND DERIVATIVES THEREOF. | |
| WO2010046926A3 (en) | Novel stilbene analogs | |
| WO2015068175A3 (en) | An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof | |
| MY156233A (en) | Disubstituted tetrahydrofuranyl compounds as antagonists of the bradykinin b1 receptor | |
| EA200801549A1 (en) | NEW PENANTRIDINE DERIVATIVES AS ANTAGONISTS OF BRADIKININ | |
| WO2014197345A3 (en) | Imidazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug | |
| WO2014049612A3 (en) | Processes and polymorphs of 5-[4-[4-(5-cyano-1h-indol-3-yl) butyl]-1-piperazinyl]-2-benzofuran carboxamide and its salts | |
| IN2013MU02001A (en) | ||
| EA201001252A1 (en) | Method of producing derivatives of 3,6-dihydro-1,3,5-triazine | |
| ME01521B (en) | Antibacterial quinoline derivatives |